ERD

Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Validation of a Lower Back “Wearable”-Based Sit-to-Stand and Stand-to-Sit Algorithm for Patients With Parkinson's Di...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Iron as a therapeutic target for Parkinson's disease

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Bioavailable Trace Metals in Neurological Diseases

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral scleros...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Validation of a Step Detection Algorithm during Straight Walking and Turning in Patients with Parkinson’s Disease and ...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of P...

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Comparison of Internal Standard Approaches for SRM Analysis of Alpha-Synuclein in Cerebrospinal Fluid

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Report on status of posting results in the study registry

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Communication and Dissemination tools including website

Project: FAIR-PARK-II

Updated at: 29-04-2024

Show more information

Project acronym FAIR-PARK-II

Periodic Reporting for period 5 - FAIR-PARK-II (Conservative iron chelation as a disease-modifying strategy in Parkinson...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotem...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Seven Solutions for Neuroprotection in Parkinson's Disease

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and ce...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinic...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared wi...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Poly‐ GP in cerebrospinal fluid links C9orf72 ‐associated dipeptide repeat expression to the asymptomatic phase of A...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of P...

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

Project: FAIR-PARK-II

Updated at: 28-07-2022

Show more information

Project acronym FAIR-PARK-II

Resources

Selected filters:

Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD

Validation of a Lower Back “Wearable”-Based Sit-to-Stand and Stand-to-Sit Algorithm for Patients With Parkinson's Di...

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration

Iron as a therapeutic target for Parkinson's disease

Bioavailable Trace Metals in Neurological Diseases

Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral scleros...

Validation of a Step Detection Algorithm during Straight Walking and Turning in Patients with Parkinson’s Disease and ...

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of P...

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

Comparison of Internal Standard Approaches for SRM Analysis of Alpha-Synuclein in Cerebrospinal Fluid

Report on status of posting results in the study registry

Communication and Dissemination tools including website

Periodic Reporting for period 5 - FAIR-PARK-II (Conservative iron chelation as a disease-modifying strategy in Parkinson...

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotem...

Seven Solutions for Neuroprotection in Parkinson's Disease

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and ce...

Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinic...

Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment

Serum neurofilament light chain in behavioral variant frontotemporal dementia

Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared wi...

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Poly‐ GP in cerebrospinal fluid links C9orf72 ‐associated dipeptide repeat expression to the asymptomatic phase of A...

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of P...

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay